Cargando…
SERPINA1 Peptides in Urine as A Potential Marker of Preeclampsia Severity
Preeclampsia (PE) is a multisystem disorder associated with pregnancy and its frequency varies from 5 to 20 percent of pregnancies. Although a number of preeclampsia studies have been carried out, there is no consensus about disease etiology and pathogenesis so far. Peptides of SERPINA1 (α1-antitryp...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037458/ https://www.ncbi.nlm.nih.gov/pubmed/32019243 http://dx.doi.org/10.3390/ijms21030914 |
_version_ | 1783500432711090176 |
---|---|
author | Starodubtseva, Natalia Nizyaeva, Natalia Baev, Oleg Bugrova, Anna Gapaeva, Masara Muminova, Kamilla Kononikhin, Alexey Frankevich, Vladimir Nikolaev, Eugene Sukhikh, Gennady |
author_facet | Starodubtseva, Natalia Nizyaeva, Natalia Baev, Oleg Bugrova, Anna Gapaeva, Masara Muminova, Kamilla Kononikhin, Alexey Frankevich, Vladimir Nikolaev, Eugene Sukhikh, Gennady |
author_sort | Starodubtseva, Natalia |
collection | PubMed |
description | Preeclampsia (PE) is a multisystem disorder associated with pregnancy and its frequency varies from 5 to 20 percent of pregnancies. Although a number of preeclampsia studies have been carried out, there is no consensus about disease etiology and pathogenesis so far. Peptides of SERPINA1 (α1-antitrypsin) in urine remain one of the most promising peptide markers of PE. In this study the diagnostic potential of urinary α1-antitrypsin peptides in PE was evaluated. The urinary peptidome composition of 79 pregnant women with preeclampsia (PE), chronic arterial hypertension (CAH), and a control group was investigated. Mann–Whitney U-test (p < 0.05) revealed seven PE specific SERPINA1 peptides demonstrating 52% sensitivity and 100% specificity. SERPINA1 in urine has been associated with the most severe forms of preeclampsia (p = 0.014), in terms of systolic hypertension (p = 0.01) and proteinuria (p = 0.006). According to Spearman correlation analysis, the normalized intensity of SERPINA1 urinary peptides has a similar diagnostic pattern with known diagnostic PE markers, such as sFLT/PLGF. SERPINA1 peptides were not urinary excreted in superimposed PE (PE with CAH), which is a milder form of PE. An increase in expression of SERPINA1 in the structural elements of the placenta during preeclampsia reflects a protective mechanism against hypoxia. Increased synthesis of SERPINA1 in the trophoblast leads to protein accumulation in fibrinoid deposits. It may block syncytial knots and placenta villi, decreasing trophoblast invasion. Excretion of PE specific SERPINA1 peptides is associated with syncytiotrophoblast membrane destruction degradation and increased SERPINA1 staining. It confirms that the placenta could be the origin of SERPINA1 peptides in urine. Significant correlation (p < 0.05) of SERPINA1 expression in syncytiotrophoblast membrane and cytoplasm with the main clinical parameters of severe PE proves the role of SERPINA1 in PE pathogenesis. Estimation of SERPINA1 peptides in urine can be used as a diagnostic test of the severity of the condition to determine further treatment, particularly the need for urgent surgical delivery. |
format | Online Article Text |
id | pubmed-7037458 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70374582020-03-11 SERPINA1 Peptides in Urine as A Potential Marker of Preeclampsia Severity Starodubtseva, Natalia Nizyaeva, Natalia Baev, Oleg Bugrova, Anna Gapaeva, Masara Muminova, Kamilla Kononikhin, Alexey Frankevich, Vladimir Nikolaev, Eugene Sukhikh, Gennady Int J Mol Sci Article Preeclampsia (PE) is a multisystem disorder associated with pregnancy and its frequency varies from 5 to 20 percent of pregnancies. Although a number of preeclampsia studies have been carried out, there is no consensus about disease etiology and pathogenesis so far. Peptides of SERPINA1 (α1-antitrypsin) in urine remain one of the most promising peptide markers of PE. In this study the diagnostic potential of urinary α1-antitrypsin peptides in PE was evaluated. The urinary peptidome composition of 79 pregnant women with preeclampsia (PE), chronic arterial hypertension (CAH), and a control group was investigated. Mann–Whitney U-test (p < 0.05) revealed seven PE specific SERPINA1 peptides demonstrating 52% sensitivity and 100% specificity. SERPINA1 in urine has been associated with the most severe forms of preeclampsia (p = 0.014), in terms of systolic hypertension (p = 0.01) and proteinuria (p = 0.006). According to Spearman correlation analysis, the normalized intensity of SERPINA1 urinary peptides has a similar diagnostic pattern with known diagnostic PE markers, such as sFLT/PLGF. SERPINA1 peptides were not urinary excreted in superimposed PE (PE with CAH), which is a milder form of PE. An increase in expression of SERPINA1 in the structural elements of the placenta during preeclampsia reflects a protective mechanism against hypoxia. Increased synthesis of SERPINA1 in the trophoblast leads to protein accumulation in fibrinoid deposits. It may block syncytial knots and placenta villi, decreasing trophoblast invasion. Excretion of PE specific SERPINA1 peptides is associated with syncytiotrophoblast membrane destruction degradation and increased SERPINA1 staining. It confirms that the placenta could be the origin of SERPINA1 peptides in urine. Significant correlation (p < 0.05) of SERPINA1 expression in syncytiotrophoblast membrane and cytoplasm with the main clinical parameters of severe PE proves the role of SERPINA1 in PE pathogenesis. Estimation of SERPINA1 peptides in urine can be used as a diagnostic test of the severity of the condition to determine further treatment, particularly the need for urgent surgical delivery. MDPI 2020-01-30 /pmc/articles/PMC7037458/ /pubmed/32019243 http://dx.doi.org/10.3390/ijms21030914 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Starodubtseva, Natalia Nizyaeva, Natalia Baev, Oleg Bugrova, Anna Gapaeva, Masara Muminova, Kamilla Kononikhin, Alexey Frankevich, Vladimir Nikolaev, Eugene Sukhikh, Gennady SERPINA1 Peptides in Urine as A Potential Marker of Preeclampsia Severity |
title | SERPINA1 Peptides in Urine as A Potential Marker of Preeclampsia Severity |
title_full | SERPINA1 Peptides in Urine as A Potential Marker of Preeclampsia Severity |
title_fullStr | SERPINA1 Peptides in Urine as A Potential Marker of Preeclampsia Severity |
title_full_unstemmed | SERPINA1 Peptides in Urine as A Potential Marker of Preeclampsia Severity |
title_short | SERPINA1 Peptides in Urine as A Potential Marker of Preeclampsia Severity |
title_sort | serpina1 peptides in urine as a potential marker of preeclampsia severity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037458/ https://www.ncbi.nlm.nih.gov/pubmed/32019243 http://dx.doi.org/10.3390/ijms21030914 |
work_keys_str_mv | AT starodubtsevanatalia serpina1peptidesinurineasapotentialmarkerofpreeclampsiaseverity AT nizyaevanatalia serpina1peptidesinurineasapotentialmarkerofpreeclampsiaseverity AT baevoleg serpina1peptidesinurineasapotentialmarkerofpreeclampsiaseverity AT bugrovaanna serpina1peptidesinurineasapotentialmarkerofpreeclampsiaseverity AT gapaevamasara serpina1peptidesinurineasapotentialmarkerofpreeclampsiaseverity AT muminovakamilla serpina1peptidesinurineasapotentialmarkerofpreeclampsiaseverity AT kononikhinalexey serpina1peptidesinurineasapotentialmarkerofpreeclampsiaseverity AT frankevichvladimir serpina1peptidesinurineasapotentialmarkerofpreeclampsiaseverity AT nikolaeveugene serpina1peptidesinurineasapotentialmarkerofpreeclampsiaseverity AT sukhikhgennady serpina1peptidesinurineasapotentialmarkerofpreeclampsiaseverity |